Back to Journal

SM Ophthalmology Journal

Comparing Refractive Outcomes of Standard Phacoemulsification with Femtosecond Laser-Assisted Cataract during the Initial Learning Curve and with More Experience

[ ISSN : 3068-0743 ]

Abstract Citation Introduction Patients and methods Statistical and data analysis Results Discussion References
Details

Received: 17-Apr-2017

Accepted: 23-Apr-2017

Published: 27-Apr-2017

Ildamaris Montes de Oca, Sumitra S Khandelwal, Eric J Kim, Tim Soeken, Ryan Barrett, Li Wang, Mitchell P Weikert, Douglas D Koch and Zaina Al-Mohtaseb*

Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin, NC205, Houston, TX, United States

Corresponding Author:

Zaina Al-Mohtaseb, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin, NC205, Houston, TX, United States; Tel: 713-798-5143; Email: zaina@bcm.edu

Keywords

Cataract surgery; Femtosecond-laser; Refractive outcomes

Abstract

Purpose: To analyze and compare the refractive outcomes of standard phacoemulsification with femtosecond laser-assisted cataract surgery performed during the initial learning curve and a year later by experienced surgeons.

Methods: This single-center retrospective study was divided into 3 groups: Group 1, 63 patients who underwent standard phacoemulsification (control group) prior to femtosecond laser acquisition by two anterior segment surgeons; Group 2, the first 104 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons from Feb 19, 2014 to April 30, 2014 (learning curve group) and Group 3,108 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons a year later from Feb, 2015 until June 30, 2015 (experienced group).

Results: Mean absolute refraction prediction errors were 0.37 ± 0.25 Diopters (D) in the control group, 0.30 ± 0.24 D in the “learning group” and 0.30 ± 0.24 D in the experienced group with no significant differences among groups. The percentages of eyes within 0.5 D of the targeted refraction were 69.8%, 90.5% and 82.5% in the control group, learning group, and experienced group, respectively (p

Conclusion: There was no statistically significant difference in the mean postoperative refraction prediction errors between femtosecond laser-assisted cataract surgery and standard phacoemulsification in either the learning curve or experienced group. However, a higher percentage of patients were within 0.5 D of the targeted refraction in the learning curve femtosecond laser-assisted cataract surgery group compared with the standard phacoemulsification group.

Citation

Montes de Oca I, Khandelwal SS, Kim EJ, Soeken T, Barrett R, Wang L, et al. Comparing Refractive Outcomes of Standard Phacoemulsification with Femtosecond Laser-Assisted Cataract during the Initial Learning Curve and with More Experience. SM Opthalmol J. 2017; 3(1): 1010.

Introduction

Cataract extraction is the most commonly performed ophthalmic surgical procedure in the world. It has grown dramatically in the past few decades with new surgical techniques and technologies, bringing improvements in visual outcomes and patient safety [1]. Femtosecond laser assisted cataract surgery (FLACS) is a technological advance that emerged in 2008. Femtosecond lasers use near-infrared light (wavelength of 1053 nm) with ultra-short pulse durations on the order of 10-15 s (quadrillionth of a second), disrupting the tissue with micron precision and a smaller zone of collateral damage [2,3].

FLACS is a growing technology that allows automation of the early steps of cataract surgery with the creation of an anterior capsulotomy, lens fragmentation, astigmatic corneal relaxing incisions, and Clear Corneal Incisions (CCIs), including the main cataract incision and paracenteses [2]. The potential advantages of FLACS as compared to conventional phacoemulsification include a more precise capsulotomy, significant reduction in required ultrasonic energy, more exact wound architecture, and decreased collateral tissue damage. These benefits may result in enhanced safety and precision, leading to more predictable refractive outcomes and reduced incidence of intra operative and post-operative complications [4,5].

The purpose of this study was to analyze and compare the outcomes of standard phacoemulsification with Femtosecond Laser-Assisted Cataract Surgery (FLACS) during the initial learning curve and a year later as experienced surgeons at a single academic center.

Patients and methods

This retrospective study included patients who underwent cataract and IOL surgery by two anterior segment surgeons (DDK, MPW). The study was divided into 3 groups: Group 1: patients who underwent standard phacoemulsification (control group) prior to acquisition of the femtosecond laser, Group 2: the first patients who underwent FLACS using the Catalys femtosecond laser (Abbott Medical Optics, Santa Ana, CA, USA) from Feb 19, 2014 to April 30, 2014 (learning curve group), and Group 3: patients who underwent FLACS a year later from Feb, 2015 to June, 2015 (experienced group). All surgeries were performed at a single center (Alkek Eye Center, Baylor College of Medicine). The inclusion criteria were patients who underwent standard phacoemulsification or FLACS using the Catalys femtosecond laser for anterior capsulotomy creation, lens fragmentation, and relaxing incisions, and who achieved best-corrected visual acuity of at least 20/40 or better by one month postoperatively. Exclusion criteria were prior ocular surgery, implantation of a multifocal IOL, and complications requiring additional surgery or vitrectomy. The data collected were entered into a standard computerized database for subsequent analysis and included patient demographics (age, gender), preoperative target spherical equivalent (SE) value measured by the Lenstar (Haag-Streit, Koeniz, Switzerland) using the Holladay 1 formula, postoperative month one Corrected Distance Visual Acuity (CDVA), and manifest refraction

Statistical and data analysis

For the sample size calculation, we wish to detect a difference of 2/3 of the standard deviation of differences between the two groups. With a significance level of 5% and a test power of 80%, 36 eyes are required in each group. We included 63 eyes in each group.

All data were collected on an Excel spreadsheet (Microsoft Office 2010). The refractive prediction error (RPE) of each group was calculated by subtracting each patient’s one-month post-operative refraction from their predicted post-operative refraction (based on the LenStar optical biometry data and the Holladay 1 formula).

A one sample t-test was used to assess if the mean arithmetic RPEs produced by each group was significantly different from zero. The nonparametric Mann-Whitney test was used to compare the absolute RPEs between groups and the chi-square test was performed to compare percentage values between groups. SPSS 22.0 for Windows (SPSS Inc, Chicago, IL) was used for statistical analysis. P<0.05 was considered statistically significant.

Results

Patient demographics were similar between the three groups. The mean age was 73.7 years ± 7.0 (SD) in the control group, 70.8 years ± 8.5 (SD) in the learning group, and 70.9 years ± 8.3 (SD) in the experienced group. The number of patients enrolled in each group was 48, 54 and 49, respectively. Each group in our study had 63 eyes: control group (36 right, 27 left), learning group (36 right, 27 left), and experienced group (29 right, 34 left).

Table 1 shows the mean absolute and numerical RPE of each group. Mean absolute Refraction Prediction Errors (RPEs) were 0.37 ± 0.25 D in the control group, 0.30 ± 0.24 D in the learning curve group, and 0.30 ± 0.24 D in the experienced group with no significant differences among groups. Mean numerical RPEs were not significantly different from zero (all p>0.05) (Table 1).

Table 1: Refractive prediction error for each group

 

Control group

Learning group

Experienced group

 

Absolute

(D)

Numerical

(D)

Absolute

(D)

Numerical

(D)

Absolute

(D)

Numerical

(D)

Mean

0.37

-0.03

0.30

0.04

0.30

0.01

SD

0.25

0.45

0.24

0.38

0.24

0.38

Min

0.00

-0.84

0.0

-1.05

0.01

-0.81

Max

0.93

0.93

1.06

1.06

1.06

1.06

D= Diopters.

The percentages of eyes within 0.5D of the targeted refraction were 69.8%, 90.5%, and 82.5% of eyes in the control, learning, and experienced groups, respectively (Figure 1).

Figure 1: Percentage of eyes vs Refractive Prediction Error (RPE). Only the control group compared to the learning group showed a significant difference in eyes within 0.5 D.

The difference between the control group and the learning group was statistically significant (p0.05) (Figure 2).

Figure 2: Percentage of eyes in each group with postoperative CDVA better than 20/25. No statistically significant difference among the three groups (p>0.05).

Discussion

Previous publications concerning femtosecond laser assisted cataract surgery discuss several aspects of the emerging technology, such as intraoperative complication rate, efficacy of capsulotomy, Effective Phacoemulsification Time (EPT), reduction to zero ultrasound (US) energy, and endothelial cell loss over time [4,6-8] As with the introduction of any new technology, a learning curve is associated with the use of this laser technology, which seems to improve with experience. To our knowledge, there are no published data comparing a control group with both early and late FLACS refractive outcomes, as is done in this study.

Several peer-reviewed articles report refractive outcomes of femtosecond laser cataract surgery compared to standard phacoemulsification (Table 2).

Table 2: Outcomes of studies that compared femtosecond laser cataract surgery with conventional phacoemulsification.

Study

FS laser used

Type of Study

Postoperative time

Contr

ols

FALC

S

MAE

MRSE

MAE

MRSE

(D)

(D)

(D)

(D)

Chee et al.

Victus, Bausch +

Lomb

Prospective

6 weeks

0.33 ± 0.25

-0.13 ± 0.40 *

0.30 ± 0.25

-0.08 ± 0.36 *

(N=387)

(N=331)

(N=715)

(N=578)

Filkorn et al.

LenSx, Alcon

Prospective

6-12 weeks

0.50 ± 0.38

-0.58 ± 1.28

0.38 ± 0.28

-0.50 ± 1.06

(N=57)

(N=57)

(N=77)

(N=77)

Roberts et al.

LenSx, Alcon

Prospective

3 months

0.31 ± 0.24

 

0.29 ± 0.25

 

(N=113)

(N=105)

Lawless et al.

LenSx, Alcon

Prospective

3 months

0.23 ± 0.16

-0.06 ± 0.30

0.26 ± 0.25

-0.01± 0.35

(N=29)

(N=61)

Abell et al.

Catalys,

Optimedica

Prospective

3 weeks

0.45 ± 0.71

(N=150)

 

0.51 ± 0.50

 

(N=51)

Conrad-Hengerer

et al.

Catalys,

Optimedica

Prospective

6 months

 

-0.11 ± 0.55

 

-0.05 ± 0.28

(N=100)

(N=100)

Ewe et al.

Catalys,

Optimedica

Prospective

6 months

0.35±0.38

-0.1 ± 0.50

0.41±0.37

-0.07 ± 0.54

(N=888)

(N=888)

(N=988)

(N=988)

Current Study

Catalys,

Optimedica

Retrospective

3 weeks

0.37 ± 0.25

-0.53 ± 0.89

0.30 ± 0.24

-0.53 ± 0.71

(N=63)

(N=63)

(N=63)

(N=63)

MAE=Mean absolute error, MRSE= Manifest refraction spherical equivalent, n= number of eyes

* Target plano, preoperative cinlinder<1.5D, p=0.034

† Statistically significant p=0.04.

Chee et al. [9] compared visual outcomes of 794 surgeries using the VICTUS femtosecond laser (Baush & Lomb, Rochester, NY, USA) to 420 conventional phacoemulsification surgeries (controls). The mean absolute errors (MAE) of 0.30 ± 0.25 diopters and 0.33 ± 0.25 diopters, respectively, (p=0.062) and the mean squared error (MSE) of 0.16 ± 0.27 diopters and 0.17 ± 0.28 diopters, respectively, (p=0.065) were not statistically significant. Only the Manifest Refraction Spherical Equivalence (MRSE) was found to be statistically significantly lower among the laser surgeries cases (-0.08 ± 0.36) compared to the control cases (-0.13 ± 0.41) (p=0.034). However, this difference might be considered clinically negligible.

In a prospective study comparing 77 eyes who underwent laser refractive cataract surgery with the LenSx (Alcon, Fort Worth, TX, USA) to 57 eyes who underwent conventional cataract surgery, Filkorn et al. [10] found that 41.6% of eyes were within ± 0.25 D of the target refraction in the laser group compared to 28.1% in the conventional group; however, 68.8% and 64.9% were within ± 0.50 D respectively. T he MAE at least 6 weeks after surgery was significantly lower in the laser group (0.38 ± 0.28 D) than in the conventional group (0.50 ± 0.38 D) (p=0.04), although no statistically significant difference was found between the two groups in the MRSE. Roberts et al. [11] conducted a prospective study with the initial 113 consecutives eyes who underwent laser cataract surgery and 105 who had undergone manual phacoemulsification. In this study, 83.2% of patients in the laser group and 81.9% in the manual group fell within ± 0.50 D of the intended correction. The MAE was 0.29 ± 0.25 D and 0.31 ± 0.24 D for each group respectively, which was not statistically significant.

We are aware of three published studies evaluating refractive outcomes when using the Catalys femtosecond laser. In a prospective consecutive case control study, Abell et al. [7] compared 150 eyes who underwent FLACS with the Catalys laser system to 51 eyes who underwent conventional phacoemulsification and found no significant difference in MAE at the 3-week postoperative visit (0.51 ± 0.50 D and 0.45 ± 0.71 D, respectively). They also found that 57.4% and 53.6% of femtosecond laser and conventional phacoemulsification cases, respectively, were within 0.5 D error.

Conrad-Hengerer et al. [12] in a prospective study compared 100 eyes treated with the Catalys femtosecond laser and 100 fellow eyes who had conventional phacoemulsification. At the 6-month follow up visit, 90% and 70% of eyes in each group were within ± 0.50 D of the predicted refractive outcome, respectively. They also reported earlier postoperative visual recovery with FLACs when compared to the conventional group, as well as earlier refractive stability in the femtosecond laser group.

Recently, Ewe et al. [13] in a prospective, multicenter study evaluated the visual outcomes after femtosecond laser-assisted cataract surgery using the Catalys with phacoemulsification cataract surgery. They compared 988 eyes in the femtosecond laser group with 888 in the phacoemulsification cataract surgery group. At the 6 month follow up, they reported 72.2% and 82.6% of eyes within 0.5D of the predicted refractive outcome in the femto and standard groups, respectively, and a CDVA better than 20/25 of 53.3% and 53.1% in each group, respectively. Interestingly, mean absolute error was higher in the femtosecond group compared to the standard group (0.41D vs. 0.35D; p<0.0001).

While our current study adds to the published experience with the Catalys laser, it is also unique in its comparison of three different groups: standard phacoemulsification (control group), initial FLACS cases (learning group), and FLACS cases a year later (experienced group). Currently no published study has reported refractive outcomes in these three distinct groups (control, learning, and experienced).

Our study showed no statistically significant difference in the RPE between all three groups (0.37 ± 0.25 D, 0.30 ± 0.24 D, and 0.30 ± 0.24 D in control, learning, and experienced groups, respectively). Our mean absolute RPE in all three groups was lower than with other studies. Compared to other studies, [7,10] our results showed a higher percentage of patients with 0.5 D or less error. 69.8%, 90.5%, and 82.5% of eyes in the control, learning, and experienced groups, respectively were within 0.5D of the targeted refraction, but only the difference between the FLACS learning curve group and the SP group was statistically significant (p=0.016). We are uncertain why there was no significant difference between the control and the experienced groups. This could be due to the fact that we were very careful with the first patients that we picked to perform FLACS on. As we became more comfortable with the technology, we performed the procedure on patients with denser and more difficult cataracts. The percentages of patients with BCVA better than 20/25 were equal among all three groups.

Our study showed similar refractive predictability when looking at RPE for femtosecond-assisted cataract surgery compared to standard phacoemulsification in both the learning curve and one year later, although we had a higher percentage of eyes within 0.5D in the FLACS groups. Conrad-Hengerer’s study showed a statistically significant difference in the RPE. The difference between our study and theirs could be due to the fact that we compared the refractive outcomes of our groups at the 3-week postoperative visit, while they compared them at 6 months postoperatively. Theoretically, the benefits of FLACS and its precise capsulotomy might not occur until long after the three-week visit, when contraction of the bag can affect refractive outcomes, which could be why they found a difference.

Limitations of this study are: 1) It is retrospective; 2) the cases in the 3 groups were sequential and not randomized or even concurrent, so the superior outcomes in the early group could be due to selection bias or improved IOL calculation methodology, and 3) the short follow up, as noted above.

More prospective studies with the Catalys Femtosecond laser are needed. We conclude that both FLACS and manual phacoemulsification result in excellent refractive outcomes.

References

1. Chen H, Hyatt T, Ahshari N. Visual and refractive outcomes of laser cataract surgery. Curr Opin Ophthalmol. 2014; 25: 49-53.

2. Abauzeid H, Ferrini W. Femtosecond-laser assisted cataract surgery: a review. Acta Ophthalmol. 2014; 92: 597-603.

3. Liu HH, Hu Y, Cui HP. Femtosecond laser in refractive and cataract surgeries. Int J Ophthalmol. 2015; 8: 419-426.

4. Abell RG, Darian-Smith E, Kan JB, et al. Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: Outcomes and safety in more than 4000 cases at a single center. J Cataract Refract Surg. 2015; 41: 47-52

5. Abell RG, Kerr NM, Vote BJ. Femtosecond laser-assisted cataract surgery compared with conventional cataract surgery. Clin Exp Ophthalmol. 2013; 41: 455-462.

6. Roberts TV, Lawless M, Bali, SJ, et al. Surgical outcomes and safety of femtosecond laser cataract surgery. Ophthalmol. 2013; 120: 227-233.

7. Abell RG, Kerr NM, Vote, BJ. Toward zero effective phacoemulsification time using femtosecond laser pretreatment. Ophthalmol. 2013; 120: 942-948.

8. Day AC, Gartry DS, Maurino V, Allan BD, Stevens JD. Efficacy of anterior capsulotomy creation in femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2014; 40: 2031-2034.

9. Chee SP, Yang Y, Ti SE. Clinical outcomes in the first two years of femtosecond laser-assisted cataract surgery. Am J Ophthalmol. 2015; 159: 714-719.

10. Filkorn T1, Kovács I, Takács A, Horváth E, Knorz MC, Nagy ZZ. Comparison of IOL power calculation and refractive outcome after laser refractive cataract surgery with a femtosecond laser versus conventional phacoemulsification. J Refract Surg. 2012; 28: 540-544.

11. Roberts TV, Lawless M, Chan CC, Jacobs M, Ng D, Bali SJ, et al. Femtosecond laser cataract surgery: technology and clinical practice. Clin Exp Ophthalmol. 2013; 41:180-186.

12. Conrad-Hengerer I, Al Sheikh M, Hengerer FH, Schultz T, Dick HB. Comparison of visual recovery and refractive stability between femtosecond laser-assisted cataract surgery and standard phacoemulsification: Six months follow up. J Cataract Refract Surg. 2015; 41: 1356-1364.

13. Ewe SY, Abell RG, Oakley CL, Lim CH, Allen PL, McPherson ZE, et al. A comparative cohort study of visual outcomes in femtosecond laser assisted versus phacoemulsification cataract surgery. Ophthalmol. 2016; 123: 178 182.

14. Lawless M, Bali SJ, Hodge C, Roberts TV, Chan C, Sutton G. Outcomes of femtosecond laser cataract surgery with a diffractive multifocal intra-ocular lens. J. Refract Surg. 2012; 28: 859-864.

15. Donaldson KE, Braga-Mele R, Cabot F, Davidson R, Dhaliwal DK, Hamilton R, et al. Femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2013; 39: 1753-1763.

16. Miháltz K, Knorz MC, Alió JL, Takács AI, Kránitz K, Kovács I, et al. Internal aberrations and optical quality after femtosecond laser anterior capsulotomy in cataract surgery. J Refract Surg. 2011; 27: 711-716.

17. Mastropasqua L, Toto L, Mastropasqua A, Vecchiarino L, Mastropasqua R, Pedrotti E, et al. Femtosecond laser versus manual clear corneal incision in cataract surgery. J Refract Surg. 2014; 30: 27-33.

18. Trikha S, Turnbull AM, Morris RJ, Anderson DF, Hossain P. The journey to femtosecond laser-assisted cataract surgery: new beginnings or a false dawn? Eye. 2013; 27: 461-473.

19. Chen M, Swinney C, Chen M. Comparing the intraoperative complication rate femtosecond laser-assisted cataract surgery to traditional phacoemulsification. Int J Ophthalmol. 2015; 8: 201-203

Other Articles

Article Image 1

Application of Anti-Scarring Drugs and Drug Delivery Systems in Glaucoma Surgeries

Anti-scarring Drugs And Drug Delivery systems (DDSs) that are more effective and safer than mitomycin C have been sought to improve the outcome of glaucoma filtration surgeries. Drugs that selectively inhibit wound healing, including anti-transforming growth factor-β and anti-vascular endothelial growth factor antibodies, have been investigated, although their advantages are yet to be verified in humans. In addition, novel sustained release DDSs with fewer toxic effects have been studied for application after glaucoma surgeries. Several potential biomaterials for such DDSs, including gelatin hydrogel, have been introduced.

Tetsuya Sugiyama


Article Image 1

Biorbital Lymphoma with Severe Exophthalmos

A 34-year-old man presented with binocular proptosis for half a year and sight lost for seven days. The patient had a facial lymphoma resection and postoperative chemotherapy five years ago.

Dajiang Wang¹ and Boyan Fang²*


Article Image 1

Research Progress and Human Clinical Trials of Mesenchymal Stem Cells in Ophthalmology: A Mini Review

Ocular diseases are devastating as most of them would cause irreversible visual impairment and blindness. Conceptually, cell replacement therapy with new ocular cells generated by ocular stem cells can substitute the degenerated or damaged cells in the diseased tissue. This concept has first been applied in the limbal transplantation by limbal progenitor cells. Unfortunately, patients with limbal stem cell deficiency and the endogenous progenitor cells present in human corneal endothelium as well as retina have limited regenerative power. In recent decades, other stem cell sources for ocular cell regeneration have been explored and are now feasible with the use of pluripotent stem cells, such as the embryonic stem cells (ESCs) and the induced pluripotent stem cells (iPSCs). Nevertheless, autologous transplantation would not be applicable using ESCs, whereas the variability of reprogramming methods as well as genetic instability of iPSCs has hindered their direct applications. Alternatively, human adult stem cells, such as hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are found throughout the body and can be efficiently isolated from patients while maintaining the characteristics of self-renewal and multipotency. Superiorly, adult stem cells harness the potential to protect the ocular cells, where MSCs are able to modulate the microenvironments of the diseased eye for neuroprotection. This article compiled the current progress of MSCs in ocular research. Moreover, the updated clinical trials of adult stem cells in ocular diseases are summarized. In addition, potential challenges and future prospects of stem cell research in ophthalmology would also be discussed.

Tsz Kin Ng* and Jasmine Sum-Yee Yung


Article Image 1

Bilateral Extramacular Choroidal Neovascularization in Wet Age-Related Macular Degeneration

Purpose: Choroidal neovascularization is a common complication following several retinal conditions, most commonly age-related macular degeneration (AMD). We present a case of bilateral extramacular choroidal neovascularization in a patient with wet AMD.

Methods/Patients: Interventional Case Report. Clinical, radiologic, and angiographic correlation.

Results: An 89 year old Caucasian male with Age-related Macular Degeneration (AMD) developed bilateral vitreous hemorrhages and subretinal hemorrhages after which were noted bilateral extramacular choroidal neovascular membranes. The vitreous hemorrhage in the left eye cleared on its own, while vitrectomy was performed in the right eye. Bevacizumab (Avastin) was injected into both eyes. Eighteen months after initial presentation and three months after Bevacizumab, the patient was asymptomatic, both neovascular membranes were inactive, and visual acuity had improved to 20/70 OD and 20/100 OS.

Conclusions: We report the first case of aggressive bilateral extramacular choroidal neovascular membranes in a patient with wet AMD. The pathophysiology that causes AMD to target the macula and fovea in most cases, but the extramacular region in this case, has yet to be elucidated.

Natasha A Naik*, Yannis M Paulus and Darius M Moshfeghi 


Article Image 1

Intraocular Lens Power Calculation after Intracorneal Ring Segment Surgery for the Treatment of Post-LASIK Ectasia

Objective: To describe the method of Intraocular lens (IOL) power calculation in eyes after Intracorneal Ring Segment (ICRS) surgery for the treatment of post-LASIK ectasia.

Design: Retrospective observational case-series.

Participants: Three eyes of 2 patients were included in this study.

Methods: Corneal curvature in the central effective optical zone was averaged using corneal topography and k-reading (Kr) was calculated using Jarade IR method for Kr after LASIK. The calculated Kr was used in SRK-T formula for IOL calculation. Accuracy of this IOL calculation method was judged using the manifest refraction outcome after cataract surgery. All eyes were targeted for emmetropia after cataract.

Results: In our series, one eye developed cataract after ICRS surgery for the treatment of ectasia after hyperopic LASIK (+4 D) and 2 eyes developed cataract after ICRS surgery for the treatment of ectasia after myoic LASIK (-10 D). The spherical equivalent of manifest refraction after cataract surgery was within 1.25 D in all eyes.

Conclusion: Using the average corneal curvature in the central effective optical zone to calculate Kr “by Jarade IR” method was found to be accurate in calculating IOL power in ectatic eyes treated by ICRS surgery

Elias Jarade¹#, Ali Dirani¹,²#, Ali Fadlallah MD¹,², Elias Chelala², Henry Fakhoury¹, George Cherfan¹*


Article Image 1

Unilateral Choroidal Osteoma with Choroidal Neovascularization

Purpose: Choroidal osteoma is a rare tumor which features intraocular bone formation. This tumor can be complicated by choroidal neovascularization which is a cause of impaired vision in this condition. We present a case of choroidal osteoma with choroidal neovascularization as a complication.

Methods: Case report with clinical and angiographic correlation.

Results: A 16 year old female presented with a choroidal osteoma in the left eye complicated by choroidal neovascularization. The patient was treated with Bevacizumab; an intravitreal anti-Vascular Endothelial Growth Factor (Anti-VEGF). Following treatment there was improvement in vision as well as resolution of the choroidal neovascular membrane.

Conclusion: We present a case of choroidal osteoma with choroidal neovascular membranes. Subfoveal Choroidal Neovascularization (CNV) associated with choroidal osteoma may be safely treated with bevacizumab. Larger studies are required to fully evaluate the management and long-term outcomes of anti-VEGF therapy for CNV associated with choroidal osteoma.

Courtney M Crawford¹ and Okezie C Igboeli²*


Article Image 1

Retinal Hemorrhage after Infliximab Use

Infliximab is a chimeric monoclonal antibody against Tumor Necrosis Factor-α (TNF-α), initially developed for treatment of rheumatoid arthritis and inflammatory bowel disease

Es Souiri J¹, Abourazzak FE¹, Andaloussi Idrissi B² and Harzy T¹*


Article Image 1

Giant Retinal Tear Retinal Detachment Etiologies, Surgical Outcome and Incidence of Recurrent Retinal Detachment after Silicon Oil Removal

Purpose: To evaluate etiologies, management, and outcomes of patients with Giant Retinal Tears (GRT) undergoing primary surgery at tertiary referral center.

Methods: A Retrospective, consecutive case series of 94 patients with at least 3 months follow up after silicon oil removal. 57 eyes (60.6%) underwent vitrectomy, 36 eyes (38.3%) underwent combined vitrectomy with buckling and 1 eye (1.1%) underwent scleral buckling. Perfluorocarbon (PFCL) heavy liquid to flatten GRT f lap intraoperative has been used then PFCL air exchange then air silicon exchange in all eyes undergoing vitrectomy. Fellow eye was observed for retinal detachment.

Results: Idiopathic cause constitute 47 eyes (50%), 25 eyes (26.6%) are myopic and 22 eyes (23.4%) have history of trauma. 85 eyes (90.4%) achieved anatomic success. Visual acuity at the last follow-up was at least 20/400 in 71 eyes (75.5%) of patients. Recurrent retinal detachment after Silicon Oil Removal (SOR) was found in 21 eyes (22.3%) of which, 50% had Proliferative Vitreoretinopathy Grade C (PVR-C) or more (p value 0.03) and 20% had GRT size more than 180° (p value 0.04). Pars Plana Vitrectomy (PPV) alone (p value 0.89) or combined PPV with buckling (p value 0.98) have no significant correlation with recurrent Retinal Detachment (RD). 21% of the fellow eye had retinal detachment.

Conclusion: Idiopathic cause constitutes the majority 50%. Patients with GRT who underwent surgery achieved high anatomic success rate. PVR-C or more remain the most significant risk factor for recurrent RD after SOR whereas PPV alone or combined PPV with buckling have no significant correlation with recurrent RD.

 

Eman Abo Taleb


Article Image 1

Macular Hole Surgery after Treatment with Ocriplasmin for Full Thickness Idiopathic Macular Holes with Vitreomacular Traction

Purpose: To report the efficacy of Ocriplasmin in the treatment of small-medium sized idiopathic full thickness Macular Holes with focal Vitreomacular traction in comparison with vitreous surgery.

Methods: Retrospective observational single-centre small case series (n=6) studythat included patients who underwent vitrectomy after unsuccessful treatment ofsmall-medium size full thickness Idiopathic macular holes with ocriplasmin.

Results: 6 eyes with full-thickness macular holes and VMT were included, whereby in 4 eyes an epiretinal membrane was present (66.7%). Resolution of VMT after intravitreal injection of ocriplasmin was shown in three out of six eyes (50%) and in all six eyes after vitrectomy (100%). Of all six eyes presenting macular holes with a mean size of 265 µm ± 109 µm at baseline visit, five eyes showed persistent macular holes at the second follow-up visit with a mean size of 335 µm ± 166 µm. After vitrectomy no macular hole could be detected at the f inal follow-up visit.

Conclusion: We present our clinical experience with intravitreous injection of Ocriplasmin to confirm the presumed therapeutic effect in patients suffering from Vitreomacular Traction (VMT) with small-medium sizedfull thickness Macular holes (MH). Small macular holes could frequently be closed with only Ocriplasmin and without surgery with a 17% closure rate. Enlargement in all holes that failed to close with Ocriplasmin was observed in all treated eyes which makes us believe that the VMT could have a Protective role. Ellipsoid zone disruptions were evident in 50% of treated eyes and more common in eyes with successful VMT release. Although data on Ocriplasmin from several studies remain controversial but so far the results are consistent with the results and recommendations of other clinical studies and the European Medicine Agency. We agree that replacing vitrectomy for MHs with one injection of Ocriplasmin would be a very attractive option but so far Pars plana vitrectomy remain the treatment of choice for most eyes with MHs. Further Work is recommended to reveal the Cause of the ellipsoid zone Changes, the mechanisms of tractional forces and to investigate the Long term side effects of Ocriplasmin.

Khaled Helaiwa¹,², Ammar Heider², KU Bartz-Schmidt¹ and Kai Januschowski¹,²*


Article Image 1

Recurrent Vitreous Hemorrhage in Patients With Scleral-Tunneled Intraocular Lenses: Case Series With Introduction of A Novel Technique

Scleral fixated Intraocular Lenses (IOLs) have grown in popularity as an effective solution to aphakic eyes with insufficient capsular support. A rare but debilitating complication includes development of Uveitis-Glaucoma Hyphema (UGH) syndrome. Recurrent hemorrhages with UGH syndrome are even more unusual (UGH-Plus syndrome). Classically, this syndrome develops following anterior chamber IOLs, but the literature is scarce with reference to UGH-Plus syndrome after posterior chamber IOL implantation. We present two cases of patients with scleral-tunneled IOLs who developed UGH-Plus syndromeresulting from haptic interference with ciliary body vessels. We describetwo different IOL sparing management approaches including introduction of a novel surgical solution.

Crystal Le, Lena Al-Dujaili and Ramesh Ayyala*